Friday, December 20, 2013

IVF success could double with new way of detecting faulty egg cells

In a study that could change the prospects for the 1 in 15 infertile couples worldwide, researchers in China and the US show how their way of finding genetic defects in egg cells could double the success rate of the reproductive treatment in vitro fertilization.


The new method, based on whole-genome sequencing of individual egg cells, could lead to an accurate, safe and cheap way to select genetically normal embryos for in vitro fertilization (IVF), thus increasing the chances of producing a healthy baby.


As well as looking for DNA sequence variations associated with known genetic disorders, the new approach detects chromosome abnormalities.


Study author Jie Qiao, department director and professor of Gynecology and Obstetrics, Peking University, 3rd Hospital, says:


"In this way, we kill two birds with one stone: one set of deep sequencing analysis to avoid two types of genetic problems."


"Theoretically, if this works perfectly, we will be able to double the success rate of test tube baby technology from 30% to 60% or even more."


The researchers write about their work in a recent online issue of the journal Cell.


New approach sequences whole genome of 'polar bodies'


In IVF, an egg from the woman is fertilized with sperm from the man in a "test tube," and the embryos are then implanted in the woman's uterus.


There are several ways to screen the embryos for genetic defects before implantation, but these carry risks because they involve removing cells from the embryo. Also, they do not detect chromosome abnormalities and genetic disorders based on DNA sequence variations at the same time.


Although whole-genome sequencing has recently been developed for screening sperm cells, until now there was not an equivalent way to apply it egg cells, despite the fact they are more likely to contain chromosome abnormalities.


In their study, the researchers developed a way of sequencing the whole of the genetic code of "polar bodies" - cells that emerge when egg cells divide but then die off, so they can be safely removed without harming the embryo.


Co-author Sunney Xie, Mallinckrodt Professor of Chemistry and Chemical Biology at Harvard University in the US, and also of Peking University, says they are now starting to test their new approach in clinical trials, and:



"If the clinical trial works, this technique could enormously increase the success rate of IVF, especially for older women or women who have had recurrent miscarriages."



In another study published earlier this year, researchers showed an IVF technique that increased pregnancy rates by 20%. The procedure, known as endometrial scratching, improved both pregnancy and birth rates when performed once in women undergoing reproductive treatment.


Written by Catharine Paddock PhD


Nearly 8% of hip implants not backed by safety evidence

Almost 8% of all implants used in hip replacement surgery have no readily available evidence relating to their safety or effectiveness, finds a study published on bmj.com today.The researchers say the current regulation process "seems to be entirely inadequate" and they call for a revised system for introducing new orthopaedic devices.The high failure rate of some metal-on-metal hip replacements has highlighted the need for an adequate evidence base for orthopaedic implants.

Government's voluntary approach to improving hospital food is not working, argues expert

As the government announces a review of hospital food, Katharine Jenner, Chair of the Campaign for Better Hospital Food, argues that only by setting legally binding standards for hospital food can it ensure that inpatients get served high quality, nourishing meals.In an article published on bmj.com today, she says the government has wasted more than £54 million of taxpayers' money on twenty one failed voluntary initiatives to improve hospital food since 1992 - enough to pay for thirty four new hospital kitchens.

First treatment for infants with CAPS licensed in UK

Anakinra (Kineret®), an interleukin-1 (IL-1) inhibitor, has been granted a licence for treatment of CAPS in children and adults by the Medicines and Healthcare Products Regulatory Agency (MHRA). Anakinra is the first CAPS treatment licensed for use in children as young as eight months. CAPS is an umbrella term for a number of ultra-rare, life-long, severely debilitating autoinflammatory diseases which cause rash, headache, fever, joint pain and other inflammatory symptoms. CAPS affects approximately 1 in 1,000,000 people in the UK.

Manufacturing low-cost artificial cells

Easily manufactured, low-cost artificial cells manufactured using microprinting may one day serve as drug and gene delivery devices and in biomaterials, biotechnology and biosensing applications, according to a team of Penn State biomedical engineers. These artificial cells will also allow researchers to explore actions that take place at the cell membrane."In a natural cell, so much is going on inside that it is extremely complex," said Sheereen Majd, assistant professor of biomedical engineering.

How a protein complex revs up T cell activation to fight infections

St. Jude Children's Research Hospital scientists have identified a protein complex that is essential for jump-starting the immune response during the critical first 24 hours of an infection. The research appears in the current issue of the scientific journal Immunity.Researchers showed the protein complex mTORC1 helps to ensure that newly activated T cells have the energy necessary to launch proliferation. T cells are white blood cells that fight disease and promote immune system balance.

A year in medicine: review of 2013

What has this last year delivered for medicine and health, and has 2013 shone more light on an area that interests you? Perhaps there has been radical change affecting a particular medical condition this year. Could it even be that medicine as a whole took a big step forward over the last 12 months?


The medical community has certainly reported major changes and offered many glimpses into tomorrow's world - and 2014 could be just as exciting.


This passing year happens to mark MNT's first decade on the web. So, with a theme connecting medicine today, yesterday and tomorrow, this is the Medical News Today end-of-year review for 2013.


Making body parts


Would it have been possible back in 2003 to imagine the reality of 3D printing 10 years later, let alone that it could help in the creation of an artificial human ear?


Another area that offers hope for tissue engineering (among many other potential benefits) is stem cell research. But, beset with scientific struggle and ethical controversy, stem cell developments have not emerged so smoothly in the last 10 years.


There was a big moment in 2013, however, when body cells were at last successfully turned into human embryonic stem cells for the very first time.


This gives reality to the prospect of cloning human tissue to fix the body - but it also reminds us of the fear that someone, somehow, could possibly clone a whole human.


Computers and gadgets